Grenzach-Wyhlen, Germany

Matthias Koerner

This inventor holds 30 USPTO granted patents and 1 published patent application, plus 1 CIPO patent and 18 EPO patents, primarily in Pharmaceutical Chemistry. Top assignee: Hoffmann-La Roche Inc.. Active years: 2006-2022.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Matthias Koerner. Retrieved from https://idiyas.com/inventor/matthias-koerner

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 30 

% Patents Active = 43.3

 

 

Average Co-Inventor Count = 5.6

ph-index = 4

Forward Citations = 65(Granted Patents)


Location History:

  • Antdorf, DE (2006 - 2009)
  • Grenzach-Wyhlen, DE (2011 - 2022)
  • Basel, CH (2022)

Company Filing History:


Years Active: 2006-2022

Loading Chart...
Loading Chart...
Loading Chart...
Areas of Expertise:
Imidazol Derivatives
Pyridine Compounds
Tau-PET-Ligands
PDE10A Inhibitors
Pharmaceutical Agents
Heterocycles
Kinase Inhibitors
Imaging Methods
Hydroxamates
Thiophene Derivatives
Aryl Derivatives
Carboxylic Acids
30 patents (USPTO):Explore Patents

Title: Matthias Koerner - Innovator in Molecular Imaging Tools

Introduction

Matthias Koerner is a prolific inventor based in Grenzach-Wyhlen, Germany, known for his significant contributions to the field of molecular imaging. With an impressive portfolio of 30 patents, he has made remarkable strides in developing innovative small molecule imaging tools.

Latest Patents

Among his recent patents, two noteworthy inventions stand out. The first patent focuses on 2-hetaryl imidazol[1,2-a]pyridine derivatives, which relate specifically to small molecule imaging tools. This invention includes compounds of formula II and pharmaceutically acceptable acid addition salts, with variations in R-R as defined in the specifications. The second patent describes a process for the preparation of 2-(6-nitropyridin-3-yl)-9H-dipyrido[2,3-b;3',4ʹ-d]pyrrole. The process involves coupling a specific compound with a suitable boronic acid under controlled conditions, along with isolation steps to yield the desired product as an acid addition salt.

Career Highlights

Matthias Koerner has established his career at Hoffmann-La Roche Inc., a leading company in the pharmaceutical industry. His work primarily focuses on innovations that enhance imaging technologies, making significant contributions to research and development in healthcare.

Collaborations

Throughout his career, Koerner has collaborated with talented coworkers, including Luca Claudio Gobbi and Alexander Flohr. These collaborative efforts have helped to push the boundaries of research and development in molecular imaging, driving the advancement of medical applications.

Conclusion

Matthias Koerner exemplifies the spirit of innovation in the field of molecular imaging. With his extensive patent portfolio and commitment to research, he continues to influence the development of new technologies that pave the way for breakthroughs in healthcare and imaging sciences.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…